Vline Pharmachem Private Limited, a active private limited company, was established on 20 April 2013 in Hyderabad, Telangana, India. Engaging in specialty chemicals within the manufacturing sector, it holds CIN: U24301TG2013PTC087124. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹5.00 Cr.
Formerly known as Vline Agri And Pharmachem Private Limited. It upholds a compliant status. Its leadership includes Kanakadurga Isukapally Bhavani (Director), Siva Rama Raju Isukapalli (Director), Venkata Narasimha Raju Isukapally (Managing Director). Past directors included Kanakadurga Isukapally Bhavani, Vani Rama Devi Penmetsa, Siva Rama Raju Isukapalli. It holds ₹12.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H.No-2-40/147/Part/Rae/201, Flat No-201, Reliance Avans Exotica, Kothaguda, Konda, Pur,, Hyderabad, Telangana, 500081.
U24301TG2013PTC087124
087124
20 April 2013
₹5.00 Cr
₹5.00 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Vline Pharmachem Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kanakadurga Isukapally Bhavani | Director | 20 Dec 2017 | Current |
| Siva Rama Raju Isukapalli | Director | 28 Sep 2024 | Current |
| Venkata Narasimha Raju Isukapally | Managing Director | 20 Apr 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 07 Sep 2018 | Past |
| Pramod Abcsdd | Director | 21 Dec 2017 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Director | 30 Sep 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Vline Pharmachem Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 83.23% decrease. The company also saw a substantial improvement in profitability, with a 55.99% increase in profit. The company's net worth dipped by a decrease of 8.92%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Vline Pharmachem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹120,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Oct 2021 | Others | ₹12.00 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Vline Pharmachem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Vline Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vline Pharmachem's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Vline Pharmachem Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Siva Rama Raju Isukapalli was appointed as a Director was appointed as a Director on 28 Sep 2024 & has been associated with this company since 1 year 2 months . was recorded as a recent event.
The activity Vline Pharmachem Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
A charge with Others amounted to Rs. 12.00 Cr with Charge ID 100491145 was registered on 25 Oct 2021. was recorded as a recent event.
Progress on Kanakadurga Isukapally Bhavani was appointed as a Director was appointed as a Director on 20 Dec 2017 & has been associated with this company since 8 years 4 days . was documented.
The activity Venkata Narasimha Raju Isukapally was appointed as a Managing Director was appointed as a Managing Director on 20 Apr 2013 & has been associated with this company since 12 years 8 months . was completed.
The CIN of Vline Pharmachem Private Limited is U24301TG2013PTC087124.
Vline Pharmachem Private Limited is headquartered at H.No-2-40/147/Part/Rae/201, Flat No-201, Reliance Avans Exotica, Kothaguda, Konda, Pur,, Hyderabad, Telangana, 500081.
Vline Pharmachem Private Limited was incorporated on 20 April 2013.
The current directors of Vline Pharmachem Private Limited are
The primary industry of Vline Pharmachem Private Limited is Manufacturing.
Vline Pharmachem Private Limited is unlisted.
The authorized capital of Vline Pharmachem Private Limited is ₹5.00 Cr, and the paid-up capital is ₹5.00 Cr.
The compliance status of Vline Pharmachem Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX